Ying-chieh Chiang

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Concomitant autoimmunity and late cancers in adult-onset immunodeficiency due to neutralizing anti-IFN-γ autoantibodies.

Concomitant autoimmunity and late cancers in adult-onset immunodeficiency due to neutralizing anti-IFN-γ autoantibodies.

Journal: Frontiers in immunology
Published: November 11, 2024

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Journal: Oncotarget
Published: April 14, 2016

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.

Journal: Oncotarget
Published: December 25, 2015

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.

Journal: Annals of hematology
Published: July 02, 2014

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.

Journal: PloS one
Published: June 17, 2014

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Journal: American journal of hematology
Published: October 02, 2013

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.

Journal: American journal of hematology
Published: September 19, 2013

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

Journal: Blood
Published: November 15, 2011
Showing 1-8 of 8

Last Updated: 09/26/2026